Dendritic cell fusion vaccines for cancer immunotherapy. - Wikidata - awgldk - TriplyDB

Dendritic cell fusion vaccines for cancer immunotherapy.

Dendritic cell fusion vaccines for cancer immunotherapy.

http://www.wikidata.org/entity/Q36150517

about

In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.A microfluidic approach towards hybridoma generation for cancer immunotherapy Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity.Strategies used for MUC1 immunotherapy: preclinical studies.MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.Evolution of cellular immunotherapy: from allogeneic transplant to dendritic cell vaccination as treatment for multiple myeloma.Immunotherapy for multiple myeloma.Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines.Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.Deformability-based microfluidic cell pairing and fusion.Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?

P2860

Q34382848-31A30F38-01B2-49A6-9A2C-681CAA46A30F Q36629413-2CA34227-752D-419C-BBB1-A434AD5E04D1 Q36959191-3E37EEEB-5AB7-45EF-96FB-ED680F3F2E68 Q37259594-E2696F6D-9F18-4D4B-9BF9-9E51090C946C Q37737313-B99FE3A1-60A3-44F9-B45A-83B9F3583307 Q38059517-39D972BC-4D25-40AA-9012-885CD9502A7E Q38177879-9C851025-0ACB-4F11-BBAF-BBB82083F13E Q38227953-84069009-FF99-4A8E-8368-D0C59A089341 Q38843235-584F1A64-A872-4045-BA57-ACB63A11740E Q38988199-910C0491-122C-4012-8BC7-EA12BFBC8E31 Q39568256-FFB142F0-CBFD-4CEE-9DA6-F9C73046BF18 Q45417047-1CE722C8-3B25-47DE-8585-9309096BBE44

P2860

Dendritic cell fusion vaccines for cancer immunotherapy.

http://www.wikidata.org/entity/Q36150517

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Dendritic cell fusion vaccines for cancer immunotherapy.

@ast

Dendritic cell fusion vaccines for cancer immunotherapy.

@en

type

label

Dendritic cell fusion vaccines for cancer immunotherapy.

@ast

Dendritic cell fusion vaccines for cancer immunotherapy.

@en

prefLabel

Dendritic cell fusion vaccines for cancer immunotherapy.

@ast

Dendritic cell fusion vaccines for cancer immunotherapy.

@en

P1433

Q36150517-D9303738-D342-49E0-B6D4-0CB4371DFB79

P1476

Q36150517-D994FA5C-089D-4FBC-9F4B-66CC4601FC86

P2093

Q36150517-00C125AD-B5EC-4CDB-AE7E-8336E88337D8

Q36150517-47353998-9804-436E-A3BE-9B7BF949DF0F

Q36150517-FF355806-4B77-4A2B-86D3-038F8B821497

P2860

Q36150517-019CC351-F879-469D-BDE9-5E5DE340869B

Q36150517-025D2C27-2ECA-4B36-B240-76BE05B384A4

Q36150517-043D9827-3DD1-48EE-A853-B24BCDBC031E

Q36150517-0536E7CF-AEDE-4604-B555-858AA2E25EF2

Q36150517-08A08798-156F-47B7-841A-888A2E3DF2F3

Q36150517-09B2DFA1-8A82-4EF3-B403-CBC25878F054

Q36150517-0CDC4492-B3AE-4DA3-B04D-7C44F1890979

Q36150517-0F110A46-E5C1-4E95-943E-AFCD5940168C

Q36150517-11903AC1-A0D1-4411-8441-2B699DDDF987

Q36150517-155D4C29-DDF1-4927-A6D9-0FD0620C14F7

P304

Q36150517-2288F2C6-05F1-4484-B250-0540FFCA8310

P31

Q36150517-51373FD8-6E29-476A-A5A7-9938F6F3ACF2

P356

Q36150517-31603F14-C2C6-4072-AB48-B19A5B7E5535

P407

Q36150517-6D2BA9D0-7FA6-4250-8338-7B83FB9D610E

P433

Q36150517-788F95FF-60BB-4EC9-AA90-2FA1A3B2C670

P478

Q36150517-2F3A350F-891A-49A6-AC85-0A6C19825CDE

P577

Q36150517-73DD87C8-D70E-4212-8CBC-E4B0ADF81724

P698

Q36150517-8B1BE6DC-033A-47C4-B649-0108A8C2E8C5

P921

Q36150517-B97AEBD9-4AE5-46A9-BBF6-E490F45AA700

P356

14712598.5.5.703

P1433

Expert Opinion on Biological Therapy

P1476

Dendritic cell fusion vaccines for cancer immunotherapy.

@en

P2093

David Avigan

http://www.w3.org/2001/XMLSchema#string

Donald Kufe

http://www.w3.org/2001/XMLSchema#string

Jacalyn Rosenblatt

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

Human tumor antigens recognized by T lymphocytes

Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice

Immunobiology of dendritic cells

The dendritic cell system and its role in immunogenicity

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

Dendritic cells: development, function and potential use for cancer immunotherapy.

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery.

Dendritic cell-tumor cell hybrid vaccination for metastatic cancer.

P304

703-715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.5.5.703

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15934845

http://www.w3.org/2001/XMLSchema#string

P921